ethyl pyruvate has been researched along with Blood Poisoning in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (68.00) | 29.6817 |
| 2010's | 7 (28.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, C; Ding, W; Duan, Z; Li, J; Li, W; Liu, B; Sun, S; Wang, K; Wang, X; Yang, C | 1 |
| Chen, LW; Chen, W; Hong, GL; Lian, J; Lu, ZQ; Mo, QF; Qin, J; Ye, JJ; Zhao, GJ; Zhi, SC | 1 |
| Breithaupt-Faloppa, AC; Correia, CJ; Ferreira, SG; Guarda, IF; Martinez, MB; Moreno, AC; Rocha-e-Silva, M; Sannomiya, P | 1 |
| Chen, J; Chen, M; Guan, X; Jiang, Z; Li, X; Lin, Z | 1 |
| Ding, G; Gao, YH; Pan, SM; Wang, HR; Xu, WP; Zheng, YJ | 1 |
| Huang, J; Li, S; Li, X; Li, Y; Mu, D; Qu, Y; Zhao, F; Zhu, T | 1 |
| Li, M; Meng, M; Qin, C; Zhang, Y | 1 |
| Barochia, A; Cui, X; Eichacker, PQ; Li, X; Li, Y; Su, J | 1 |
| Deng, ZH; Lin, J; Ti, DD; Wang, LH; Xue, H; Yan, GT | 1 |
| Cai, B; Deitch, EA; Ulloa, L | 1 |
| Akalin, B; Altun, H; Aydin, MT; Ekci, B; Karip, AB; Memisoglu, K; Onur, E | 1 |
| Czura, CJ; Fink, MP; Halperin, D; Ochani, M; Tanovic, M; Tracey, KJ; Ulloa, L; Yang, H; Yang, R | 1 |
| Hewitt, SM; Hu, X; Iyer, S; Miyaji, T; Muramatsu, Y; Star, RA; Yuen, PS | 1 |
| Fink, MP | 5 |
| Han, PL; Kim, JB; Kim, SY; Lee, JK; Lee, KW; Yu, YM | 1 |
| Das, UN | 2 |
| Lever, A; Mackenzie, I | 1 |
| Cui, X; Eichacker, PQ; Fitz, Y; Hsu, L; Li, X; Li, Y; Mani, H; Quezado, M; Su, J | 1 |
| Tenhunen, JJ | 1 |
| Dellinger, RP; Nahra, R | 1 |
11 review(s) available for ethyl pyruvate and Blood Poisoning
| Article | Year |
|---|---|
Can we predict the effects of NF-kappaB inhibition in sepsis? Studies with parthenolide and ethyl pyruvate.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Humans; Mice; NF-kappa B; Pyruvates; Sepsis; Sesquiterpenes | 2009 |
Novel insights for systemic inflammation in sepsis and hemorrhage.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Choline; Cytokines; Disease Models, Animal; Hemorrhage; HMGB1 Protein; Humans; Inflammation; Nicotinic Agonists; Nootropic Agents; Pyruvates; Receptors, Nicotinic; Sepsis | 2010 |
Ethyl pyruvate: a novel treatment for sepsis and shock.
Topics: Humans; Pyruvates; Sepsis; Shock, Septic | 2004 |
Pyruvate is an endogenous anti-inflammatory and anti-oxidant molecule.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cytokines; Free Radicals; Glucose; Humans; Insulin; Macrophage Migration-Inhibitory Factors; Pyruvates; Pyruvic Acid; Sepsis; Tumor Necrosis Factor-alpha | 2006 |
Is pyruvate an endogenous anti-inflammatory molecule?
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Critical Illness; Cytokines; Disease Models, Animal; Free Radical Scavengers; Humans; Insulin; Macrophage Migration-Inhibitory Factors; Myocardial Infarction; NF-kappa B; Pyruvates; Pyruvic Acid; Sepsis; Signal Transduction | 2006 |
Ethyl pyruvate: a novel treatment for sepsis.
Topics: Animals; Humans; Pyruvates; Sepsis | 2007 |
Ethyl pyruvate: a novel treatment for sepsis.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Humans; Mice; Pyruvates; Sepsis | 2007 |
Management of sepsis.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; HMGB1 Protein; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulins; Multiple Organ Failure; Nicotinic Agonists; Prognosis; Pyruvates; Sepsis | 2007 |
Targeting the lipopolysaccharides: still a matter of debate?
Topics: Antibodies, Bacterial; Antimicrobial Cationic Peptides; Bacterial Vaccines; Cathelicidins; Curcumin; Emulsions; Endotoxemia; Endotoxins; Humans; Incidence; Lipopolysaccharides; Phospholipids; Pyruvates; Sepsis | 2008 |
Ethyl pyruvate.
Topics: Anti-Inflammatory Agents; Humans; Neuroprotective Agents; Pancreatitis; Pyruvates; Reperfusion Injury; Sepsis; Shock, Hemorrhagic; Shock, Septic | 2008 |
Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: potential benefits of resuscitation with Ringer's ethyl pyruvate solution.
Topics: Adult; Animals; Critical Care; Disease Models, Animal; Humans; Isotonic Solutions; Multiple Organ Failure; NF-kappa B; Pyruvates; Reactive Oxygen Species; Respiratory Distress Syndrome; Resuscitation; Sepsis; Shock, Hemorrhagic | 2002 |
14 other study(ies) available for ethyl pyruvate and Blood Poisoning
| Article | Year |
|---|---|
Protective effect of ethyl pyruvate on gut barrier function through regulations of ROS-related NETs formation during sepsis.
Topics: Animals; Extracellular Traps; Hydrogen Peroxide; Intestine, Small; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Neutrophils; p38 Mitogen-Activated Protein Kinases; Protective Agents; Pyruvates; Reactive Oxygen Species; Sepsis | 2021 |
Ethyl pyruvate reverses development of Pseudomonas aeruginosa pneumonia during sepsis-induced immunosuppression.
Topics: Animals; Apoptosis; Bacterial Load; Cecum; Cytokines; Disease Models, Animal; HMGB1 Protein; Immunity, Innate; Immunosuppression Therapy; Interleukin-10; Lung; Male; Mice; Mice, Inbred BALB C; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Pyruvates; Sepsis; Spleen | 2017 |
Effects of ethyl pyruvate on leukocyte-endothelial interactions in the mesenteric microcirculation during early sepsis treatment.
Topics: Animals; Cell Communication; Disease Models, Animal; Endothelial Cells; Escherichia coli Infections; Leukocytes; Male; Mesenteric Veins; Microcirculation; Pyruvates; Rats; Rats, Wistar; Sepsis | 2015 |
Ethyl pyruvate reduces hepatic mitochondrial swelling and dysfunction in a rat model of sepsis.
Topics: Animals; Aquaporins; Benzimidazoles; Carbocyanines; Disease Models, Animal; Humans; Liver; Liver Diseases; Male; Mitochondria, Liver; Mitochondrial Swelling; Pyruvates; Random Allocation; Rats; Rats, Sprague-Dawley; Sepsis | 2015 |
Expression of HMGB1 in septic serum induces vascular endothelial hyperpermeability.
Topics: Actins; Antigens, CD; Apoptosis; bcl-2-Associated X Protein; Cadherins; Capillary Permeability; Cytoskeleton; Endothelium, Vascular; Female; HMGB1 Protein; Human Umbilical Vein Endothelial Cells; Humans; Male; Middle Aged; Pyruvates; Sepsis | 2016 |
Role of HMGB1 translocation to neuronal nucleus in rat model with septic brain injury.
Topics: Active Transport, Cell Nucleus; Animals; Brain Injuries; Cell Count; Cell Nucleus; Cerebral Cortex; HMGB1 Protein; Male; Neurons; Neuroprotective Agents; Pyruvates; Rats, Wistar; Receptor for Advanced Glycation End Products; Sepsis; Transcription Factor RelA | 2017 |
Effect of ethyl pyruvate on physical and immunological barriers of the small intestine in a rat model of sepsis.
Topics: Analysis of Variance; Animals; Bacterial Translocation; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Immunohistochemistry; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Kaplan-Meier Estimate; Male; Probability; Pyruvates; Random Allocation; Rats; Rats, Wistar; Sepsis; Survival Analysis | 2009 |
[Effects of ethyl pyruvate on injuries of sepsis in mice].
Topics: Alkaline Phosphatase; Animals; Disease Models, Animal; Intestines; Lactic Acid; Lung; Male; Mice; Pyruvates; Pyruvic Acid; Sepsis; Uric Acid | 2009 |
Ethyl pyruvate improves healing of colonic anastomosis in a rat model of peritonitis.
Topics: Analysis of Variance; Anastomosis, Surgical; Animals; Colon; Disease Models, Animal; Hydroxyproline; Male; Peritonitis; Pressure; Pyruvates; Rats; Rats, Wistar; Sepsis; Wound Healing | 2012 |
Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation.
Topics: Animals; Cell Line; Endotoxemia; Enzyme Activation; HMGB1 Protein; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pyruvates; RNA, Messenger; Sepsis; Signal Transduction; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha | 2002 |
Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice.
Topics: Acute Kidney Injury; Aging; Animals; Anti-Bacterial Agents; Blood Coagulation; Cecum; Cysteine-Rich Protein 61; Disease Models, Animal; Fibrinolysis; Fluid Therapy; Gene Expression; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney Tubules; Ligation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Pyruvates; RNA, Messenger; Sepsis; Tumor Necrosis Factor-alpha; Wounds, Stab | 2003 |
Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window.
Topics: Animals; Brain; Brain Injuries; Brain Ischemia; Coloring Agents; Cytokines; Dose-Response Relationship, Drug; Immunoblotting; Immunohistochemistry; Infarction, Middle Cerebral Artery; Inflammation; Ischemia; Lipopolysaccharides; Male; Microglia; Neuroprotective Agents; Neuropsychological Tests; Nitric Oxide; Pyruvates; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Sepsis; Tetrazolium Salts; Time Factors | 2005 |
Ethyl pyruvate decreased early nuclear factor-kappaB levels but worsened survival in lipopolysaccharide-challenged mice.
Topics: Animals; Cytokines; Kidney; Lipopolysaccharides; Lung; Mice; Mice, Inbred C57BL; NF-kappa B; Proportional Hazards Models; Pyruvates; Sepsis; Treatment Failure | 2008 |
Bull's eye missed by the magic bullet: preclinical investigations, publication bias, and promising new interventions.
Topics: Animals; Cytokines; Disease Models, Animal; Lipopolysaccharides; Mice; NF-kappa B; Publication Bias; Pyruvates; Sepsis | 2008 |